| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Centre for Respiratory Research,* University College London, The Rayne Institute, London, United Kingdom; and the Departments of Medicine and Pathology, Tulane University Health Sciences Center, New Orleans, Louisiana
Activation of the coagulation cascade is commonly observed in the lungs of patients with both acute and chronic inflammatory and fibrotic lung disorders, as well as in animal models of these disorders. The aim of this study was to examine the contribution of the major thrombin receptor, proteinase-activated receptor-1 (PAR-1), during the acute inflammatory and chronic fibrotic phases of lung injury induced by intratracheal instillation of bleomycin in mice. Inflammatory cell recruitment and increases in bronchoalveolar lavage fluid (BALF) protein were attenuated by 56 ± 10% (P < 0.05) and 53 ± 12% (P < 0.05), respectively, in PAR-1-deficient (PAR-1–/–) mice compared with wild-type (WT) mice. PAR-1–/– mice were also protected from bleomycin-induced pulmonary fibrosis with total lung collagen accumulation reduced by 59 ± 5% (P < 0.05). The protection afforded by PAR-1 deficiency was accompanied by significant reductions in pulmonary levels of the potent PAR-1-inducible proinflammatory and profibrotic mediators, monocyte chemoattractant protein-1 (MCP-1), transforming growth factor-ß-1 (TGF-ß1), and connective tissue growth factor/fibroblast-inducible secreted protein-12 (CTGF/FISP12). In addition, PAR-1 was highly expressed in inflammatory and fibroproliferative lesions in lung sections obtained from patients with fibrotic lung disease. These data show for the first time that PAR-1 signaling plays a key role in experimentally induced lung injury, and they further identify PAR-1 as one of the critical receptors involved in orchestrating the interplay between coagulation, inflammation, and remodeling in response to tissue injury.
This article has been cited by other articles:
 |
|
 |
|
  L. Atzori, M. Lucattelli, C. J. Scotton, G. J. Laurent, B. Bartalesi, G. De Cunto, B. Lunghi, R. C. Chambers, and G. Lungarella Absence of Proteinase-Activated Receptor-1 Signaling in Mice Confers Protection from fMLP-Induced Goblet Cell Metaplasia Am. J. Respir. Cell Mol. Biol., December 1, 2009; 41(6): 680 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Orbe, J. A. Rodriguez, O. Calvayrac, R. Rodriguez-Calvo, C. Rodriguez, C. Roncal, S. Martinez de Lizarrondo, J. Barrenetxe, J. C. Reverter, J. Martinez-Gonzalez, et al. Matrix Metalloproteinase-10 Is Upregulated by Thrombin in Endothelial Cells and Increased in Patients With Enhanced Thrombin Generation Arterioscler Thromb Vasc Biol, December 1, 2009; 29(12): 2109 - 2116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-C. Yu, M.-J. Hsu, M.-L. Kuo, R. F.-C. Chen, M.-C. Chen, K.-J. Bai, M.-C. Yu, B.-C. Chen, and C.-H. Lin Thrombin-Induced Connective Tissue Growth Factor Expression in Human Lung Fibroblasts Requires the ASK1/JNK/AP-1 Pathway J. Immunol., June 15, 2009; 182(12): 7916 - 7927. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Mato, M. Fujii, Y. Hakamata, E. Kobayashi, A. Sato, M. Hayakawa, H. Ohto-Ozaki, M. Bando, S. Ohno, S. Tominaga, et al. Interleukin-1 receptor-related protein ST2 suppresses the initial stage of bleomycin-induced lung injury Eur. Respir. J., June 1, 2009; 33(6): 1415 - 1428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Y. Xu, J. Porte, A. J. Knox, P. H. Weinreb, T. M. Maher, S. M. Violette, R. J. McAnulty, D. Sheppard, and G. Jenkins Lysophosphatidic Acid Induces {alpha}v{beta}6 Integrin-Mediated TGF-{beta} Activation via the LPA2 Receptor and the Small G Protein G{alpha}q Am. J. Pathol., April 1, 2009; 174(4): 1264 - 1279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. F. Mercer, R. H. Johns, C. J. Scotton, M. A. Krupiczojc, M. Konigshoff, D. C. J. Howell, R. J. McAnulty, A. Das, A. J. Thorley, T. D. Tetley, et al. Pulmonary Epithelium Is a Prominent Source of Proteinase-activated Receptor-1-inducible CCL2 in Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., March 1, 2009; 179(5): 414 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Chambers Abnormal wound healing responses in pulmonary fibrosis: focus on coagulation signalling Eur. Respir. Rev., December 1, 2008; 17(109): 130 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J Allan, J. Beattie, and D. J Flint Epithelial injury induces an innate repair mechanism linked to cellular senescence and fibrosis involving IGF-binding protein-5 J. Endocrinol., November 1, 2008; 199(2): 155 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fineschi, M. Bongiovanni, Y. Donati, S. Djaafar, F. Naso, L. Goffin, C. Barazzone Argiroffo, J.-C. Pache, J.-M. Dayer, S. Ferrari-Lacraz, et al. In Vivo Investigations on Anti-Fibrotic Potential of Proteasome Inhibition in Lung and Skin Fibrosis Am. J. Respir. Cell Mol. Biol., October 1, 2008; 39(4): 458 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Chen, A. Carpenter, J. Abrahams, R. C. Chambers, R. I. Lechler, J. H. McVey, and A. Dorling Protease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1-dependent leukocyte recruitment in vivo J. Exp. Med., August 4, 2008; 205(8): 1739 - 1746. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Shpacovitch, M. Feld, M. D. Hollenberg, T. A. Luger, and M. Steinhoff Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity J. Leukoc. Biol., June 1, 2008; 83(6): 1309 - 1322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Deng, P. F. Mercer, C. J. Scotton, A. Gilchrist, and R. C. Chambers Thrombin Induces Fibroblast CCL2/JE Production and Release via Coupling of PAR1 to G{alpha}q and Cooperation between ERK1/2 and Rho Kinase Signaling Pathways Mol. Biol. Cell, June 1, 2008; 19(6): 2520 - 2533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Laurent, R. J. McAnulty, M. Hill, and R. Chambers Escape from the Matrix: Multiple Mechanisms for Fibroblast Activation in Pulmonary Fibrosis Proceedings of the ATS, April 15, 2008; 5(3): 311 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Scotton and R. C. Chambers Molecular Targets in Pulmonary Fibrosis: The Myofibroblast in Focus Chest, October 1, 2007; 132(4): 1311 - 1321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wygrecka, P. Markart, C. Ruppert, K. Petri, K. T. Preissner, W. Seeger, and A. Guenther Cellular origin of pro-coagulant and (anti)-fibrinolytic factors in bleomycin-injured lungs Eur. Respir. J., June 1, 2007; 29(6): 1105 - 1114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Fang, X. Liu, M. Al-Mugotir, T. Kobayashi, S. Abe, T. Kohyama, and S. I. Rennard Thrombin and TNF-{alpha}/IL-1beta Synergistically Induce Fibroblast-Mediated Collagen Gel Degradation Am. J. Respir. Cell Mol. Biol., December 1, 2006; 35(6): 714 - 721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Chua and G. J. Laurent Neutrophil elastase: mediator of extracellular matrix destruction and accumulation. Proceedings of the ATS, July 1, 2006; 3(5): 424 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Spoken sessions Thorax, December 1, 2005; 60(suppl_2): ii4 - ii52. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
